From Research to Application: Technology Transfer at FLI

It’s crucial for the German research infrastructure to transfer new technologies, methods and intellectual property from research to application and commercial utilization. The revenues generated in this way may subsequently finance further research projects. Moreover, as an institute primarily funded by the federal and state government, our whole research and work should eventually be utilized for the benefit of the public.

At FLI, we do research on the foundation of phenomena and biological processes which as of now have not been described or fully understood. However, it’s always our objective to identify and utilize potential targets for biomedical intervention, ultimately aiming at the development of novel therapeutic concepts for age-related diseases.

FLI’s technology transfer is primarily focusing on two application fields: the provision of libraries and databases as well as the transfer of research findings into concrete cures.

Libraries & Databases

One core value of good scientific practice is the transparency of processes underlying scientific knowledge gain. In order to make our research replicable and accessible to the international scientific community, we develop, maintain and support several databases.

DiProDB - Dinucleotide Property Database

DiProGB - The Dinucleotide Properties Genome Browser

Enterobacter Genome Browser–engine

Jena Library of Biological Macromolecules

Jena Prokaryotic Genome Viewer – JPGV

Jena3D Viewer

Spirochetes Genome Browser – SGB

Technology

At the FLI, internal and external competencies are bundled in an efficient structure for technology transfer, thus following the BMBF-granted Leibniz-guidelines to implement and strengthen technology transfer in research institutes. Internally, the research coordinator and the legal department have responsibility for this matter. For the exploitation of its intellectual property, FLI collaborates with Ascenion, an exclusive technology transfer partner within life sciences.

Examples for transfer projects from relevant research findings at FLI are as follows:

Aß-directed peptides

Cell wall-less bacteria

GFP Transgenic Zebrafish

Notch-inhibitor for cancer treatment

PARP1-/- mice

Treatment of osteoporosis

P21 Inhibitors

Contact

Dr. Wilfried Briest

Wilfried Briest
Research Coordinator
+49 3641 65-6371
koordinator@leibniz-fli.de

Heidrun Lekscha
Assistance
+49 3641 65-6333
heidrun.lekscha@leibniz-fli.de